Identification of known drugs that act as inhibitors of NF-κB signaling and their mechanism of action
- 11 January 2010
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 79 (9), 1272-1280
- https://doi.org/10.1016/j.bcp.2009.12.021
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cardiac Glycosides Inhibit p53 Synthesis by a Mechanism Relieved by Src or MAPK InhibitionCancer Research, 2009
- Identification of compounds that potentiate CREB signaling as possible enhancers of long-term memoryProceedings of the National Academy of Sciences, 2009
- Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growthProceedings of the National Academy of Sciences, 2008
- Dynamic Effect of Bortezomib on Nuclear Factor-κB Activity and Gene Expression in Tumor CellsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2008
- Compound Management for Quantitative High-Throughput ScreeningSLAS Technology, 2008
- Compound Cytotoxicity Profiling Using Quantitative High-Throughput ScreeningEnvironmental Health Perspectives, 2008
- Characterization of Diversity in Toxicity Mechanism Using in Vitro Cytotoxicity Assays in Quantitative High Throughput ScreeningChemical Research in Toxicology, 2008
- TNF‐mediated inflammatory diseaseThe Journal of Pathology, 2007
- Emetine Regulates the Alternative Splicing of Bcl-x through a Protein Phosphatase 1-Dependent MechanismChemistry & Biology, 2007
- Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical librariesProceedings of the National Academy of Sciences, 2006